The difference between the amount and the type of volatile organic compounds(VOCs) on exhaled breath of patients with cholangiocarcinoma and patients with benign biliary conditions

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Observational

Source

TCTR

Registry ID

TCTR20190907002

Enrollment

Registered

2019-09-07

Start date

2018-10-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholangiocarcinoma Benign biliary conditions &#45

Interventions

Cholangicarcinoma patients who have hot been treated with CMT and has no recently infection

Diagnostic

Cholangicarcinoma patients

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: - CCA and non-CCA patients with biliary conditions - Age 18-80 years

Exclusion criteria

Exclusion criteria: - Patients with other cancers - Patient with active biliary tract infection (< 4 weeeks) - CCA patients who has been treated with chemotherapy or currently treat with chemotherapy

Design outcomes

Primary

Measure	Time frame
To identify changes in the profile of VOCs in exhaled breath of patients with CCA compared to other 1 year exhaled breath	—

Secondary

Measure	Time frame
a diagnostic model for CCA 1 year exhaled breath	—

Countries

Thailand

Contacts

Public ContactNanicha Siriwong

Faculty of medicine, Chulalngkorn university

yambluess14@gmail.com0837190462

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026